Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HOME CLINIC PREGNANCY TEST

K-Number: K883826 · 1988-11-29

ApplicantVanguard Biomedical Corp.
Decision Date1988-11-29
Product CodeLCX
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

HOME CLINIC PREGNANCY TEST is the device name listed in this FDA 510(k) record. The listed applicant is Vanguard Biomedical Corp.. It received FDA 510(k) clearance on 1988-11-29 under 510(k) number K883826. The device is classified under product code LCX. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HOME CLINIC PREGNANCY TEST?

HOME CLINIC PREGNANCY TEST is a medical device that received FDA 510(k) clearance on 1988-11-29. The listed applicant is Vanguard Biomedical Corp.. The 510(k) number is K883826.

When did HOME CLINIC PREGNANCY TEST receive FDA 510(k) clearance?

HOME CLINIC PREGNANCY TEST received FDA 510(k) clearance on 1988-11-29, under 510(k) number K883826.

Who is the listed applicant for HOME CLINIC PREGNANCY TEST?

The FDA 510(k) record lists Vanguard Biomedical Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HOME CLINIC PREGNANCY TEST?

The FDA product code for HOME CLINIC PREGNANCY TEST is LCX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Vanguard Biomedical Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K960733MINISTICK PREGNANCY TESTK960233MINICLINIC OVULATION PREDICTORK930014PROCLINIC ONE-STEP DIPSTICK PREGNANCY TESTK914254HOMECLINIC ONE STEP PREGNANCY TESTK914253PROCLINIC ONE STEP PREGNANCY TESTK910351MINICLINIC OVULATION PREDICTION TEST

View all 10 devices →

Related Devices (Code: LCX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K251040MissLan® Early Detection Digital Pregnancy Test; MissLan® Early Result Digital Pregnancy TestGuangzhou Decheng Biotechnology Co., Ltd.K251053Shinetell PlusTM Digital Early Pregnancy TestHangzhou AllTest Biotech Co., Ltd.K250117FaStep Pregnancy Rapid Test Cassette; Fastep HCG Rapid Test CassetteAssure Tech., LLCK242135Synthgene Home Test HCG Test Strip; Synthgene Home Test HCG Test Cassette; Synthgene Home Test HCG Test MidstreamNanjing Synthgene Medical Technology Co., Ltd.K243573FaStep Early Pregnancy Rapid Test Strip; FaStep Early Pregnancy Rapid Test Cassette; FaStep Early Pregnancy Rapid Test MidstreamAssure Tech., LLCK241394iHealth® Early Pregnancy Test; iHealth® Early Pregnancy Test StripAndon Health Co, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑